molecular residual disease

3 · 20 / page

Ask MedXY AI

Latest news

Tag

Gastroenterologyadjuvant chemotherapycirculating tumor DNA

Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases

By MedXY|Jul 4, 2026

This study reveals that circulating tumor DNA (ctDNA) status after colorectal liver metastasis surgery predicts survival outcomes and benefits from adjuvant chemotherapy, guiding personalized treatment.

Postoperative Lymph ctDNA Outperforms Plasma in Predicting Early Recurrence of HPV-Independent Head and Neck Cancer

newsctDNAhead and neck cancer

molecular residual disease

Latest news

Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases

Postoperative Lymph ctDNA Outperforms Plasma in Predicting Early Recurrence of HPV-Independent Head and Neck Cancer

Predictive Power of Circulating Tumor DNA in Managing Resected Extrahepatic Cholangiocarcinoma